by IR Team | Apr 14, 2022 | Press Releases
LOS ANGELES, April 14, 2022 — Sera Labs, a wholly subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced its Seratopical Revolution skincare line will be sold at select Walmart Stores, as well as CVS, and Bed Bath & Beyond stores. Sera...
by IR Team | Mar 3, 2022 | Press Releases
COFEPRIS (Mexico’s equivalent of the US FDA) grants authorization for the manufacture, distribution and sale in Mexico of CURE’s Sildenafil, Vitamin D3, Electrolyte, Energy, and Sleep products in CURE’s patented Oral Thin Film (OTF) dose form...
by IR Team | Dec 9, 2021 | Press Releases
Northern Response International To Distribute Seratopical Revolution® Masstige LineLOS ANGELES and TORONTO, Dec. 09, 2021 — The Sera Labs, a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR) today announced its global expansion into...
by IR Team | Nov 16, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company focused on pharmaceutical and health & wellness products, announced today that it received an issue...
by IR Team | Aug 17, 2021 | Press Releases
OXNARD, Calif. – CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021, including the following highlights: Revenue of $2.1 million reflected an increase of nearly 700% from a year ago Gross profit rose 676%...